Volume 27, Number 1—January 2021
Dispatch
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin
Table 1
Sample ID | Age, y/sex | Sampling month | Location | Travel history | Symptoms | Day serum sample taken after RT-PCR–confirmed SARS-CoV-2 infection |
---|---|---|---|---|---|---|
1 | 36/M | March | Cotonou | France | Fever | 8 |
2 | 43/M | March | Cotonou | Niger | Fever | 1 |
3 | 34/F | March | Cotonou | France | Fever | 8 |
4 | 29/M | March | Cotonou | France | Fever | 10 |
5 | 44/M | April | Cotonou | Germany | Fever | 10 |
6 | 39/F | April | Cotonou | France | Fever | 9 |
7 | 41/F | April | Cotonou | France | Fever | 8 |
8 |
37/M |
April |
Cotonou |
Germany |
Fever |
8 |
*ID, identification; RT-PCR, reverse transcription PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. |
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: November 02, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.